Skip to main content

Table 1 The demographic and clinical variables of a training set of patients with malignant SPNs, patients with benign SPNs, and healthy smokers

From: Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

 

32 Patients with malignant SPNs

33 Patients with benign SPNs

29 Healthy controls

Age, Median (SD)

66.2 (8.3)

64.7 (12.9)

66.5 (7.1)

Sex

   

   Female

12 (37.5%)

13(39.4%)

10 (34.5%)

   Male

20 (62.5%)

20 (60.6%)

19 (65.5%)

Race

   

   African American

8 (25.0%)

9 (27.3%)

8 (27.6%)

   White

24 (75.0%)

24 (72.7%)

21 (72.4%)

Nodule size, Median (SD)

2.6 (1.8)

1.1 (1.7)

 

Pack-years, Median (SD)

35.5 (26.8)

30.0 (30.2)

35.0 (22.8)

Stages of NSCLC

   

   stage I

11 (34.4%)

  

   stage II

8 (25.0%)

  

   stage III-IV

13 (40.6%)

  

Histological types of NSCLC

   

   AC

18 (56.3%)

  

   SCC

14 (43.7%)

  

Diagnosis of benign SPNs

   

   Inflammatory lesion

 

27 (81.8%)

 

   Sarcoid

 

3 (9.1%)

 

   Granuloma

 

2 (6.1%)

 

   Fibrosis

 

1 (3.0%)

 
  1. Abbreviations: SPNs, solitary pulmonary nodules; SD, standard deviation; NSCLC, non-small-cell lung cancer; AC, adenocarcinoma; SCC, squamous cell carcinoma